Amgen has declared the appointment of Naveen Gullapalli as its new managing director. He will oversee the operations at Amgen’s Technology and Innovation facility in Hyderabad, leveraging his broad expertise across pharmaceutical, finance, and tech sectors in guiding global operations and interrelated functions.
Gullapalli transitions to Amgen after his tenure at Novartis, where he spearheaded the development of their global hub in Hyderabad and a network comprising six locations worldwide. His efforts significantly contributed to strategic growth and innovation within the company. Gullapalli’s proficiency in cultivating specialized skills and facilitating business transformation aligns perfectly with Amgen’s aims for their Hyderabad site as a leading technology and innovation hub.
“We are excited to have Naveen join us. Amgen India’s role is pivotal in advancing our global aim to blend biotech with technology to fast-track innovation and address the needs of a globally aging demographic. Naveen’s extensive experience and strategic insight will propel the success of this new location,” stated Som Chattopadhyay, Amgen’s national executive for India.
“India’s talented workforce presents a significant opportunity for Amgen to achieve world-class functionality, operational prowess, innovation, and technology-driven transformation,” expressed Gullapalli.
Commencing in August 2024, the Hyderabad technology and innovation facility is a fundamental part of Amgen’s worldwide directive to hasten digital transformation and innovation activities. It is crafted to further Amgen’s commitment to reaching more patients. Initially focused on cultivating advanced technology solutions and honing digital capabilities, Amgen India aims to enhance efficiencies organization-wide, bolstering key sectors like AI, data analysis, and life sciences.